Skip to main content
  • Saved

made a Post

Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane? - ClinOwl

Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane? - ClinOwl

Source :

https://clinowl.com/use-of-pioglitazone-in-people-with-type-2-diabetes-mellitus-with-coronavirus-disease-2019-covid-19-boon-or-bane/

People with type 2 diabetes mellitus (T2DM) have increased morbidity and mortality due to coronavirus disease-19(COVID-19). It has been speculated that use of pioglitazone might increase such risk. The aim of our brief commentary is to review the safety of pioglitazone in people with T2DM and mild/moderate COVID-19.We searched PubMed database using specific keywords related to our aims till May 15, 2020.